Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder

[1]  Janice M. Fullerton,et al.  De Novo Gene Variants and Familial Bipolar Disorder , 2020, JAMA network open.

[2]  M. Daly,et al.  Exome sequencing in schizophrenia-affected parent–offspring trios reveals risk conferred by protein-coding de novo mutations , 2020, Nature Neuroscience.

[3]  M. Daly,et al.  Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations , 2019, Nature Neuroscience.

[4]  P. Zandi,et al.  De Novo Variation in Bipolar Disorder , 2019, Molecular Psychiatry.

[5]  G. Kirov,et al.  De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia , 2019, Nature Neuroscience.

[6]  T. Swigut,et al.  Single Amino Acid Change Underlies Distinct Roles of H2A.Z Subtypes in Human Syndrome , 2019, Cell.

[7]  Tadafumi Kato,et al.  Current understanding of bipolar disorder: Toward integration of biological basis and treatment strategies , 2019, Psychiatry and clinical neurosciences.

[8]  Hagen U. Tilgner,et al.  SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse , 2019, Neuron.

[9]  K. Yokochi,et al.  Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy , 2019, Nature Communications.

[10]  L. Vitale,et al.  Human protein-coding genes and gene feature statistics in 2019 , 2019, BMC Research Notes.

[11]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[12]  James C. Hu,et al.  The Gene Ontology Resource: 20 years and still GOing strong , 2019 .

[13]  Jonathan P. Beauchamp,et al.  Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences , 2019, Nature Genetics.

[14]  Rebecca C. Spillmann,et al.  Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay. , 2019, American journal of human genetics.

[15]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[16]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[17]  Yanhui Xu,et al.  Cryo-EM structure of human SRCAP complex , 2018, Cell Research.

[18]  Rafael Ayala,et al.  Structure and dynamics of the yeast SWR1-nucleosome complex , 2018, Science.

[19]  Peter J. Campbell,et al.  Population dynamics of normal human blood inferred from somatic mutations , 2018, Nature.

[20]  K. Ballman,et al.  Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.

[21]  Stanley W. K. Ng,et al.  Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.

[22]  Alicia R. Martin,et al.  Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum. , 2018, American journal of human genetics.

[23]  K. Kasai,et al.  Identification of somatic mutations in monozygotic twins discordant for psychiatric disorders , 2018, npj Schizophrenia.

[24]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[25]  K. Kasai,et al.  Identification of somatic mutations in postmortem human brains by whole genome sequencing and their implications for psychiatric disorders , 2018, Psychiatry and clinical neurosciences.

[26]  Patrick J. Short,et al.  Integrating healthcare and research genetic data empowers the discovery of 49 novel developmental disorders , 2019, bioRxiv.

[27]  N. de Leeuw,et al.  EHMT1 mosaicism in apparently unaffected parents is associated with autism spectrum disorder and neurocognitive dysfunction , 2018, Molecular Autism.

[28]  T. Hara,et al.  Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder. , 2018, Cell reports.

[29]  Joshua C Randall,et al.  Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders. , 2018, American journal of human genetics.

[30]  Ian J. Deary,et al.  Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism , 2017, Nature Genetics.

[31]  Nicola J. Rinaldi,et al.  Genetic effects on gene expression across human tissues , 2017, Nature.

[32]  R. Pfundt,et al.  Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder , 2017, PLoS genetics.

[33]  Jakob Grove,et al.  Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder , 2017, bioRxiv.

[34]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[35]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[36]  Bradley P. Coe,et al.  Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases , 2017, Nature Genetics.

[37]  H. Kim,et al.  Forebrain-specific ablation of phospholipase Cγ1 causes manic-like behavior , 2017, Molecular Psychiatry.

[38]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[39]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[40]  Y. Kamatani,et al.  A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder , 2017, Molecular Psychiatry.

[41]  N. Craddock,et al.  Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder , 2017, Translational Psychiatry.

[42]  Ó. González-Pérez,et al.  Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders. , 2016, Cytokine & growth factor reviews.

[43]  B. O’Roak,et al.  Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder , 2016, bioRxiv.

[44]  Giulio Genovese,et al.  Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia , 2016, Nature Neuroscience.

[45]  Aliz R. Rao,et al.  Rare deleterious mutations are associated with disease in bipolar disorder families , 2016, Molecular Psychiatry.

[46]  L. Vissers,et al.  Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.

[47]  V. Willour,et al.  Exome Sequencing of Familial Bipolar Disorder. , 2016, JAMA psychiatry.

[48]  O. Abe,et al.  Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis , 2016, Molecular Psychiatry.

[49]  N. Matoba,et al.  Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations , 2016, Molecular Psychiatry.

[50]  Stephan J Sanders,et al.  Refining the role of de novo protein truncating variants in neurodevelopmental disorders using population reference samples , 2016, Nature Genetics.

[51]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[52]  E. Boerwinkle,et al.  dbNSFP v3.0: A One‐Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice‐Site SNVs , 2016, Human mutation.

[53]  J. Danesh,et al.  Rare loss-of-function variants in KMT2F are associated with schizophrenia and developmental disorders , 2016, bioRxiv.

[54]  Gerald W. Zamponi,et al.  Targeting voltage-gated calcium channels in neurological and psychiatric diseases , 2015, Nature Reviews Drug Discovery.

[55]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[56]  J. Nurnberger,et al.  Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder , 2015, Nature.

[57]  Kengo Kinoshita,et al.  Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals , 2015, Nature Communications.

[58]  Yongwook Choi,et al.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..

[59]  Wei Chen,et al.  Sequence analysis A Bayesian framework for de novo mutation calling in parents-offspring trios , 2015 .

[60]  Kali T. Witherspoon,et al.  Excess of rare, inherited truncating mutations in autism , 2015, Nature Genetics.

[61]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[62]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[63]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[64]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[65]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[66]  Yadong Wang,et al.  A gradient-boosting approach for filtering de novo mutations in parent-offspring trios , 2014, Bioinform..

[67]  Amir A Mufaddel,et al.  Familial idiopathic basal ganglia calcification (Fahr’s disease) , 2014, Neurosciences.

[68]  I. Ionita-Laza,et al.  Loss-of-Function Variants in Schizophrenia Risk and SETD1A as a Candidate Susceptibility Gene , 2014, Neuron.

[69]  Allan R. Jones,et al.  Transcriptional Landscape of the Prenatal Human Brain , 2014, Nature.

[70]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[71]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[72]  D. Geschwind,et al.  Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice , 2013, Nature Genetics.

[73]  L. Siever,et al.  Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.

[74]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[75]  E. Banks,et al.  Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. , 2012, American journal of human genetics.

[76]  S. Levy,et al.  De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia , 2012, Nature Genetics.

[77]  Christian Gilissen,et al.  Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. , 2012, American journal of human genetics.

[78]  B. Faircloth,et al.  Primer3—new capabilities and interfaces , 2012, Nucleic acids research.

[79]  Jing Hu,et al.  SIFT web server: predicting effects of amino acid substitutions on proteins , 2012, Nucleic Acids Res..

[80]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[81]  Gabriele Gillessen-Kaesbach,et al.  Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. , 2012, American journal of human genetics.

[82]  Andrew Flaus,et al.  Mechanisms for ATP‐dependent chromatin remodelling: the means to the end , 2011, The FEBS journal.

[83]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[84]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[85]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[86]  R. Kessler,et al.  Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. , 2011, Archives of general psychiatry.

[87]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[88]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[89]  C. Lord,et al.  The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors , 2010, Neuron.

[90]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[91]  Stormy J. Chamberlain,et al.  Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11–q13 , 2010, Neurobiology of Disease.

[92]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[93]  Justin C. Fay,et al.  Identification of deleterious mutations within three human genomes. , 2009, Genome research.

[94]  Esben Agerbo,et al.  Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index. , 2009, The Journal of clinical psychiatry.

[95]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[96]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[97]  Tadafumi Kato,et al.  Molecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’? , 2008, Trends in Neurosciences.

[98]  W. Drevets,et al.  The Subgenual Anterior Cingulate Cortex in Mood Disorders , 2008, CNS Spectrums.

[99]  P. Donnelly,et al.  Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype , 2008, Molecular Psychiatry.

[100]  R. Freedman,et al.  Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. , 2007, The American journal of psychiatry.

[101]  C. Carter.  Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: Implications for oligodendrocyte viability , 2007, Neurochemistry International.

[102]  A. Bertelsen,et al.  Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. , 2005, Archives of general psychiatry.

[103]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[104]  P. Sham,et al.  The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. , 2003, Archives of general psychiatry.

[105]  Peter McGuffin,et al.  A twin study of genetic relationships between psychotic symptoms. , 2002, The American journal of psychiatry.

[106]  P. McGuffin,et al.  Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. , 2013, JAMA psychiatry.

[107]  R. Shelton,et al.  Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development , 2012, Neuropsychopharmacology.

[108]  Avner Schlessinger,et al.  ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI , 2012 .

[109]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[110]  H. Meltzer,et al.  Treatment of schizoaffective disorders. , 1984, Schizophrenia bulletin.